Brief: Bone Therapeutics Posts Positive Results Of ALLOB Study

Biosenic SA

30/06/2021 06:05

June 30 (Reuters) - Bone Therapeutics SA  BOTHE.BR :
    * REG-BONE THERAPEUTICS PUBLISHES RESULTS OF ALLOB PHASE
I/IIA
STUDY FOR THE TREATMENT OF DELAYED-UNION FRACTURES IN STEM CELL
RESEARCH & THERAPY
    * RESULTS SHOWED PERCUTANEOUS IMPLANTATION OF ALLOGENEIC
BONE-FORMING CELLS WAS WELL TOLERATED IN PATIENTS AND LED TO
PROMISING RADIOLOGICAL AND CLINICAL IMPROVEMENTS
    * BONE THERAPEUTICS ANTICIPATES FINALIZING PATIENT
RECRUITMENT IN
H1 2022
    * TOPLINE RESULTS ARE EXPECTED IN SECOND HALF OF 2022

Source text for Eikon:  ID:nGNE7DhLCS 
Further company coverage:  BOTHE.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))